The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Praxair's revenues will grow 6.6% and EPS will expand 4.2%.
The average estimate for revenue is $3.00 billion. On the bottom line, the average EPS estimate is $1.48.
Last quarter, Praxair tallied revenue of $2.89 billion. GAAP reported sales were 1.7% higher than the prior-year quarter's $2.84 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.38. GAAP EPS of $1.30 for Q1 were 5.8% lower than the prior-year quarter's $1.38 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 43.3%, 20 basis points better than the prior-year quarter. Operating margin was 21.6%, 50 basis points worse than the prior-year quarter. Net margin was 13.5%, 130 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $11.96 billion. The average EPS estimate is $5.95.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 678 members out of 703 rating the stock outperform, and 25 members rating it underperform. Among 151 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 148 give Praxair a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Praxair is outperform, with an average price target of $121.18.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Praxair. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Praxair to My Watchlist.